!["I can’t make [treatment] decisions for you, but I can give you realistic expectations," said Herbert Lepor, MD, of NYU Langone Health.](https://cdn.sanity.io/images/0vv8moc6/cancernetwork/11e93c561a9ff98f731b152d7f48e6f792831864-1000x1000.jpg?w=350&fit=crop&auto=format)
News|Videos|December 15, 2017
Treatment of Challenging Mantle Cell Lymphoma Cases
Author(s)Peter Martin, MD
This video reviews the treatment of mantle cell lymphoma cases that do not fit the typical mold.
Advertisement
In this video, Peter Martin, MD, of Weill Cornell Medicine in New York, discusses the treatment of mantle cell lymphoma cases that do not fit the typical mold.
Martin gave a presentation on this topic during an education session at the 2017 American Society of Hematology (ASH) Annual Meeting and Exposition, held December 9–12 in Atlanta.
Advertisement
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA Accepts NDA for Daraxonrasib in Pretreated Metastatic Pancreatic Cancer
2
RASolute 302 and the Future of Pancreatic Cancer Treatment: Paul Oberstein, MD, on the KRAS Breakthrough
3
Mapping the Full CAR T-Cell Journey in DLBCL From Referral to Survivorship
4
Balancing Oncologic Outcomes With Patient Priorities in Prostate Cancer Care
5






















































